Literature DB >> 4294531

Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis.

S Bremberg, E Klein, J Stjernswärd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4294531

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  [Virus infected lymphoblasts acting as antigen for the production of heterologous antilymphocyte sera].

Authors:  G Bandlow; F Kieling; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

Review 2.  Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors:  T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal:  Transplant Rev       Date:  1971

3.  Malignant lymphomas in transplantation patients: a review of the world experience.

Authors:  I Penn; T E Starzl
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-01

4.  Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.

Authors:  D W Roberts; G L Wolff; W L Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 5.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

6.  Effect of immunosuppression on the growth of six murine tumors.

Authors:  K Pavelic; I Hrsak
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-09-28

7.  Decreased growth capacity of passaged gross virus-induced mouse lymphomas after incubation with antithymocytic sera.

Authors:  D L Vredevoe; E F Hays
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

8.  Increased Incidence of Lymphoma in C3H/HeJ Adult Mice Injected with Gross Virus and Antithymocytic Serum.

Authors:  D L Vredevoe; E F Hays
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.